PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34986718-5 2022 Other tested B-Raf inhibitors, both type-I (dabrafenib and encorafenib) and type-II (RAF265 and AZ628), also exhibited potent therapeutic effects on SM-exposed HaCaT cells. Mustard Gas 149-151 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 13-18